In the past 52-week period, shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) have moved within the range of $0.38 to $4.95. On the stock’s most recent trading day, the company’s shares ended the regular session at $3.48, which is 29.7% higher than its 52-week high.
Ampio Pharmaceuticals, Inc. (AMPE) has demonstrated a 20-day simple moving average (SMA) of 43.98%, and a 50-day SMA of 99.56%. This public company’s current market capitalization stands at $236.61 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Publicly-traded companies normally report earnings and revenue figures that are either above or below the average Wall Street projection. In the most recent quarterly financial report, for the quarter ending Dec. 2014, Ampio Pharmaceuticals, Inc. (AMPE) delivered a 1.90% surprise with its net revenue.
Meanwhile, during the same quarter Ampio Pharmaceuticals, Inc. (AMPE) delivered a -2.56% earnings surprise. Net earnings for the quarter were posted at -$0.19 per share, whereas Wall Street had forecast -$0.19 per share.Ownership at Ampio Pharmaceuticals, Inc. (AMPE), According to Most Recent SEC Filings
We can gain important insight by taking a look at institutional ownership, as detailed in public companies’ latest 13F filings. Ampio Pharmaceuticals, Inc. (AMPE) has 0 billion shares outstanding currently, 09.11% of which belong to institutional investors. Those institutional holdings amount to $0.03 billion.
Additionally, according to the most recent 13F filing from Ampio Pharmaceuticals, Inc. (AMPE), there were 4 new positions totaling 48,581 shares of the company’s stock. There were 13 sold out positions, on the other hand, totaling 1,421,527 shares.Short, Medium and Long Term Indicators
Analyzing the average trade volume of a publicly-traded company’s stock – in the short, medium and long terms – is helpful for gaining insight into trading activity and general investor sentiment. Ampio Pharmaceuticals, Inc. (AMPE) has had a 20-day average volume of 2,602,765 shares, with an average of 60% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 1,824,250 shares, with an average of 100% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,201,788 shares with 100% of long-term indicators pointing to Buy.